Author

Docteur Runyambo

Observed name: D. Runyambo

Institution: Rwanda Biomedical Center

Observed institution: Rwanda Biomedical Center

ORCID: 0009-0006-6103-6703

Observed ORCID: 0009-0006-6103-6703

OpenAlex ID: A5106452160

Paucibacillary Tuberculosis Drives the Low Positive Predictive Value of Xpert MTB/RIF Ultra for Rifampicin Resistance Detection in Low-Prevalence Settings

2025 · Isabel Cuella-Martin, Francois Hakizayezu, et al. · Clinical Infectious Diseases · 16

High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial

2025 · J. Snobre, J. Gasana, et al. · IJTLD OPEN · 2

Spatial clustering and transmission networks of multidrug-resistant tuberculosis in Rwanda: a national retrospective genomic and spatial epidemiological study

2026 · Isabel Cuella-Martin, Francois Hakizayezu, et al. · BMJ Open

Tracking cross-border transmission of Rwanda’s successful dominant rifampicin-resistant Mycobacterium tuberculosis clone using genomic markers

2026 · Isabel Cuella-Martin, Wim Mulders, et al. · medRxiv

Drug resistance of Mycobacterium tuberculosis to linezolid and delamanid: a case report from Bukavu, Democratic Republic of Congo

2025 · Bertin C. Bisimwa, Esto Bahizire, et al. · BMC Infectious Diseases

Direct thin-layer agar for bedaquiline-susceptibility testing of Mycobacterium tuberculosis at BSL2 level yields high accuracy in 15 days from sputum processing

2025 · I. Cuella Martin, D. Runyambo, et al. · Journal of Clinical Microbiology

Works count: 6

Citation count: 18

H-index: 2

I10-index: 1